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Background: Nephrolithiasis has been associated with hypertension, obesity and 
diabetes Mellitus. The prevalence of adverse cardiovascular  outcomes among kidney 
stone formers (KSF) is unknown.  
Methods: We examined the IV Portuguese National Health Survey for documenting 
possible associations between nephrolithiasis, cardiovascular diseases, diabetes and 
obesity in the Portuguese adult population. 
Results: We obtained 23,349 questionnaires from individuals with ≥ 15 year-old. The 
prevalence of kidney stone disease was 7.3%. The prevalence of hypertension was 
higher among KSF when compared with the general population (50.4% vs. 30.2%; p 
< 0,001). Age and obesity significantly increase the risk for nephrolithiasis. After 
adjusting for age and body mass index, KSF have higher prevalence of hypertension 
(odds-ratio: 1.841; 95% CI: 1.651 – 2.053), diabetes Mellitus (odds-ratio: 1.475; 95% 
CI: 1.283 – 1.696; p < 0.001), myocardial infarction (odds-ratio: 1.338; 95% CI: 
1.003 – 1.786; p < 0.05), and stroke (odds-ratio: 1.330; 95% CI: 1.015 – 1.743; p < 
0.05) as compared with non-stone formers. 
Conclusions: Kidney stone disease is associated with a higher prevalence of chronic 
diseases and adverse cardiovascular outcomes when compared with the general 
population.  
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Introduction 
Nephrolithiasis is a relatively prevalent disease in Western civilizations 1. 
Epidemiological studies documented an association of nephrolithiasis with obesity, 
diabetes Mellitus and arterial hypertension 2-5. These comorbidities are manifestations 
of the metabolic syndrome and their high prevalence in KSF points to an involvement 
of insulin resistance in the pathophysiology of nephrolithiasis 6;7. Obesity and diabetes 
promote lithogenesis:  uric acid stones are more common in diabetic patients 8and 
obesity increases the urinary excretion of promoters of crystallization, urine acidity,  
and contributes to an increase of calcium oxalate lithogenesis 9;10. An increased risk of 
kidney stone formation was documented in obese individuals in a large prospective 
study 11 and in individuals with a high fructose consumption 12, a natural sugar 
implicated in the development of the metabolic syndrome in humans 13.  
There is some evidence of an increase of the risk factors for coronary heart disease   
in KSF 14, but there are no available data to demonstrate that this enhanced risk 
actually results in adverse clinical outcomes in KSF.  
The Portuguese National Health Survey (NHS) is an instrument of analysis with 25 
years of experience conducted by the National Health Institute Doutor Ricardo Jorge 
and the National Institute of Statistics (NIS) of Portugal 15. This instrument meets the 
international guidelines of the World Health Organization (WHO) and the 
EUROSTAT regarding health questionnaires 16;17 and is based on a large probabilistic 
population sample , randomly selected among residents in Portuguese territory. The 
fourth NHS allowed us to study possible associations between nephrolithiasis and 
diabetes Mellitus, hypertension, myocardial infarction, and stroke. 
Methods 
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The NHS is a validated questionnaire to collect responses for operating 233 variables, 
according to WHO recommendations for the development of health surveys. The data 
collection was carried out by direct interview. Interviewers were recruited by the NIS, 
being preferred not to have training in health sciences to prevent the know effect of 
focused interviews, and had specific training to conduct the interviews in sensitive 
areas. A pilot test was done in April 2005, , and data collection took place in 2005-
2006, with a total duration of 52 weeks.  
The existence of each chronic disease was coded in a dummy variable, according to 
the following criteria: a positive answer of the respondents on whether they have or 
had ever had the disease mentioned, plus a positive response whether that knowledge 
was transmitted to them by a physician or nurse. The age of onset of the disease 
and/or diagnosis, and the use of drugs or any other form of treatment were also asked. 
Anthropometric data collected at the time of questionnaires included weight and 
height. Obesity was defined as body mass index (BMI) ≥ 30 Kg/m2. 
Sample selection 
The sample used in the 4th NHS was randomly selected from a mother-sample used by 
the NIS for studies with families among residents in private households from a 
representative sample of households from the mainland and the autonomous regions 
of Azores and Madeira, using a system of stratification and systematic selection. The 
stratification of the mother-sample was made at the level of the seven regions defined 
by the Nomenclature of Territorial Units for Statistics (NUTS II) of the European 
Community. The number of individuals selected within each region was scaled to 
ensure an equitable distribution across regions, according to the results of the 2001 
census and the last NHS held in 1998.  
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The areas of the interview were selected approximately equally by quarter and week, 
to minimize possible seasonal effects of the survey results.  
We used the questionnaires of all respondents aged ≥ 15 years-old and whose answers 
were provided directly to the interviewers; proxy answers  were excluded.  
Statistical methods  
A descriptive statistics for all variables was carried out. Categorical variables were 
expressed as proportions and compared with the Chi-square. Binary logistic 
regression was used to analyze the effect of multiple explanatory variables on 
dichotomous variables.  The average of the ordinal variables was compared using the 
Mann-Whitney’s test. The t-test for independent variables was used to compare the 
means between interval variables. 
Statistical analyses were conducted using SPSS® version 13.0 for Windows (SPSS 
Inc., U.S.A.). A p value < 0.05 was considered significant. 
 
Results 
We identified 23,349 surveys who met the inclusion requirements . The prevalence of 
nephrolithiasis in this population was 7.3%. Compared with individuals without a 
history of kidney stones, KSF were older (median of the age group: 50 – 54 vs. 60 – 
64 years-old; p <0.001) (Figure 1) and have a slightly higher BMI (26.0 ± 4.5 vs. 27.2 
± 4.6 kg/m2; p <0.001). 
The prevalence of hypertension, obesity, diabetes, stroke, and myocardial infarction  
was significantly higher in KSF than in the general population (Table 1). 
After correction for age, the odds-ratio (O.R.) for obesity  was 29% higher in the 
population with nephrolithiasis compared with non-stone formers (O.R.: 1.298; 95% 
CI: 1.151 – 1.464; p < 0.001).The odds-ratio for hypertension adjusted for age and 
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BMI was higher in KSF as compared to non-stone formers (O.R.: 1.84; 95% CI: 1.151 
– 1.464; p < 0.001), and the age of onset of hypertension occurred earlier in the first 
group (49.2 ± 14.4 vs. 50.4 ± 14.4 years-old; p <0.05; respectively). 
Also for diabetes, the O.R. adjusted for age and BMI, was higher in KSF as compared 
to non-stone formers (O.R.: 1.475; 95% CI: 1.283 – 1.696; p < 0.001). We found no 
significant association between treatment for kidney stones and the development of 
diabetes. Only 489 of 1,701 KSF reported any kind of treatment for nephrolithiasis, 
67 of them were diabetic and 422 were not (P = NS). 
 After adjustment for age and BMI, the probability of myocardial infarction (O.R. 
1.338; 95% CI: 1.003 – 1.786; p < 0.05) and stroke (O.R.: 1.330; 95% CI: 1.015 – 
1.743; p < 0.05) was increased in KSF as compared to non-stone formers. After 
further adjustment for the concomitant presence of hypertension and diabetes, the 
association of nephrolitiasis with stroke did no reach significance, and the association 
of nephrolithiasis with myocardial remained significant only in women (O.R.: 1.566; 
95% CI: 1.001 – 2.448; p < 0.05). 
In individuals who reported kidney stone disease and any other of the chronic diseases 
under study, in most cases the age at onset of nephrolithiasis preceded the age of 
development of clinical manifestations of those diseases. The average age difference 
between the initial manifestations of KSD and the appearance of the other chronic 
diseases was: hypertension 2.0 ± 15.7 years, p <0.001; diabetes Mellitus 6.5 ± 14.7 
years, p <0.001; stroke 7.8 ± 13.3 years, p <0.001; myocardial infarction 8.8 ± 17.5 




This study identified significant associations between nephrolithiasis and 
hypertension, diabetes, myocardial infarction and stroke. Previous studies have 
documented an increased prevalence and incidence of hypertension in stone formers 
18;19 and a higher incidence of nephrolithiasis in hypertensive patients 20;21. To our 
knowledge, only one study published in 1973 documented an increased prevalence of 
coronary heart disease in KSF 22, and that result was not confirmed by others 23. Our 
study provides the first independent confirmation of an association between 
nephrolithiasis and coronary heart disease in a large-scale population, and also 
confirms an increased prevalence of stroke in KSF. 
In this study, the associations between nephrolithiasis and hypertension, diabetes or 
CVD were only partly justified by the older age and higher BMI of KSF. The 
relations of hypertension with age and BMI are well documented in older age groups 
24 and obese individuals 25. However, the  O.R. for hypertension in our population 
with nephrolithiasis remained higher after adjusting the results for age and BMI, 
suggesting the existence of further risk factors.   
Obesity is a known risk factor for diabetes and cardiovascular diseases 26, but in our 
study the association of nephrolithiasis with diabetes remains significant after 
adjustment for age and BMI. It is conceivable that the adverse effects of certain forms 
of treatment of kidney stone disease may result in an increased risk of diabetes and 
CVD. Thiazide diuretics are frequently used in the treatment of nephrolithiasis, and a 
possible association between low-dose thiazide diuretics an enhanced risk of diabetes  
was recently reported by Taylor et al. 27. An increased risk of diabetes has also been 
documented in patients undergoing extracorporeal shock wave lithotripsy 28. 
However, only a minor proportion of patients in our population had been submitted to 
any form of treatment for nephrolithiasis, except for symptomatic treatment, and in 
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those who were treated no association was observed between treatment and the 
development of diabetes or CVD. 
In our study, the age of the diagnosis of nephrolithiasis proceeded the age of the 
diagnosis of diabetes and other cardiovascular outcomes, in most cases by several 
years. Even considering that the onset of type 2 diabetes may precede its clinical 
diagnosis by as much as seven years 29,  kidney stone disease cannot be interpreted as 
a consequence of diabetes, as usually described in medical literature, but, instead, it 
appears to occur early in life in individuals with a greater predisposition for the future 
development of diabetes. 
In the past, the search for an association between nephrolithiasis and coronary heart 
disease gave contradictory results 22;23;30. Our results document an association 
between nephrolithiasis and myocardial infarction later in life and, in women, 
nephrolitiasis remains an independent risk factor after adjustment for the presence of 
diabetes and hypertension. 
 Li et al. 31 found a high percentage of cases with a history of kidney stones in patients 
with normal blood pressure who developed stroke over 6-year follow-up, but that 
difference did not reach statistical significance after adjustment for other risk factors . 
Our study confirms the association between nephrolithiasis and stroke and explains it 
by the higher prevalence of hypertension and diabetes observed in KSF.  
Nephrolithiasis is gradually being recognized as a systemic disease indicative of an 
adverse metabolic environment 32;33. The differences in the ages of diagnosis of the 
different co-morbidities found in our study suggests that the causal mechanism may 
already be present when the lithogenic process began, and its identification should be 
part of a more comprehensive intervention in kidney stone prevention.  
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The results express the need for prospective long-term studies to access the risk for 
CVD and diabetes in kidney stone disease and it is recommended to undertake a 
careful assessment of cardiovascular risk factors in stone forming patients. 
 
Limitations:  
The recognition of comorbidities was based on the knowledge that patients have about 
their own health status and we admit some bias related to the fact that individuals 
affected by one disease condition may have a greater probability of other conditions 
being diagnosed, simply by getting more medical attention. The operational definition 
of nephrolithiasis could not be compared with the concept used by the health 
professionals who made that diagnosis. It was not possible to identify any 
biochemical parameters related to nephrolithiasis or cardiovascular risk. The cross-
sectional nature of the study did not allow a clear identification of a causal link 
between nephrolithiasis and the  outcomes of interest.  
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Captions and labels 
 
Figure 1 – Distribution of kidney stone formers according to age. 
 
Figure 2 – Mean age of appearance of symptoms from the chronic diseases under 
consideration. *= p < 0.05; **= p < 0.001. 
 
 
Table 1 – Prevalence of chronic diseases associated with high cardiovascular risk in 
the studied population.  
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Table 1  
 
Chronic disease Overall 
(n = 23,349) 
Non-stone formers 
(n = 21,648) 
Stone formers 
(n = 1,701) 
P value 
Hypertension 30.2% 28.6% 50.4% < 0.001 
Obesity 17.3% 16.9% 22.7% < 0.001 
Diabetes 10.0% 9.4% 16.6% < 0.001 
Myocardial infarction 1.9% 1.8% 3.3% < 0.001 
Stroke 2.3% 2.1% 3.8% < 0.001 
 
